{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:11Z","timestamp":1790096051373,"version":"4.0.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"crossref","award":["U01 AA026980-06"],"award-info":[{"award-number":["U01 AA026980-06"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hepatology Rep"],"DOI":"10.1007\/s11901-025-00713-7","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:48Z","timestamp":1764249048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today\u2019s World"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-2384","authenticated-orcid":false,"given":"Sajid","family":"Jalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Pagadala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-9519","authenticated-orcid":false,"given":"Hanna","family":"Blaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elfeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"10308","key":"713_CR1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gines","year":"2021","unstructured":"Gines P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359\u201376.","journal-title":"Lancet"},{"issue":"6","key":"713_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388\u201398.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"713_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae024","volume":"12","author":"JC Lai","year":"2024","unstructured":"Lai JC, Liang LY, Wong GL. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? Gastroenterol Rep (Oxf). 2024;12:goae024.","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"713_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the L","year":"2021","unstructured":"European Association for the Study of the L. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013\u20092021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"1","key":"713_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","volume":"11","author":"G Shiha","year":"2017","unstructured":"Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, et al. Asian-Pacific association for the study of the liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11(1):1\u201330.","journal-title":"Hepatol Int"},{"key":"713_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6662760","volume":"2021","author":"R Sirli","year":"2021","unstructured":"Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: which cut-offs to use? Can J Gastroenterol Hepatol. 2021;2021:6662760.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"713_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40477-024-00971-z","volume":"28","author":"N Ahmed","year":"2025","unstructured":"Ahmed N, Kumari A, Murty RS. FibroScan\u2019s evolution: a critical 20-year review. J Ultrasound. 2025;28(2):295\u2013304.","journal-title":"J Ultrasound"},{"issue":"4","key":"713_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.cgh.2020.12.016","volume":"20","author":"K Imajo","year":"2022","unstructured":"Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, et al. Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2022;20(4):908\u201317. e11.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"713_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598\u2013607. e2.","journal-title":"Gastroenterology"},{"issue":"1","key":"713_CR10","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.2214\/AJR.19.21267","volume":"214","author":"A Furlan","year":"2020","unstructured":"Furlan A, Tublin ME, Yu L, Chopra KB, Lippello A, Behari J. Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2020;214(1):W20\u20136.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"713_CR11","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313.","journal-title":"Ultrasound Med Biol"},{"issue":"5","key":"713_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","volume":"48","author":"L Castera","year":"2008","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48(5):835\u201347.","journal-title":"J Hepatol"},{"issue":"7","key":"713_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/gut.2006.111302","volume":"56","author":"M Fraquelli","year":"2007","unstructured":"Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007;56(7):968\u201373.","journal-title":"Gut"},{"issue":"3","key":"713_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.25993","volume":"57","author":"J Boursier","year":"2013","unstructured":"Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology. 2013;57(3):1182\u201391.","journal-title":"Hepatology"},{"key":"713_CR15","first-page":"43","volume":"5","author":"E Durango","year":"2013","unstructured":"Durango E, Dietrich C, Seitz HK, Kunz CU, Pomier-Layrargues GT, Duarte-Rojo A, et al. Direct comparison of the fibroscan XL and M probes for assessment of liver fibrosis in obese and Nonobese patients. Hepat Med. 2013;5:43\u201352.","journal-title":"Hepat Med"},{"issue":"4","key":"713_CR16","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000023","volume":"10","author":"A Berger","year":"2019","unstructured":"Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, et al. Liver stiffness measurement with fibroscan: use the right probe in the right conditions! Clin Transl Gastroenterol. 2019;10(4):e00023.","journal-title":"Clin Transl Gastroenterol"},{"issue":"11","key":"713_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u201335.","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"713_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2893.2011.01534.x","volume":"19","author":"M Sasso","year":"2012","unstructured":"Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat. 2012;19(4):244\u201353.","journal-title":"J Viral Hepat"},{"issue":"4","key":"713_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12072-014-9573-1","volume":"8","author":"G Ferraioli","year":"2014","unstructured":"Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Rondanelli M, Perani G, et al. Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis. Hepatol Int. 2014;8(4):576\u201381.","journal-title":"Hepatol Int"},{"issue":"8","key":"713_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/MEG.0b013e32835f4c3d","volume":"25","author":"E Recio","year":"2013","unstructured":"Recio E, Cifuentes C, Macias J, Mira JA, Parra-Sanchez M, Rivero-Juarez A, et al. Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Hepatol. 2013;25(8):905\u201311.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"713_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/s-0043-123829","volume":"56","author":"J Galaski","year":"2018","unstructured":"Galaski J, Schulz L, Krause J, Lohse AW. Discordance in steatosis classification between liver biopsy and transient elastography for high controlled attenuation parameter (CAP) values. Z Gastroenterol. 2018;56(1):36\u201342.","journal-title":"Z Gastroenterol"},{"issue":"3","key":"713_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","volume":"67","author":"VW Wong","year":"2017","unstructured":"Wong VW, Petta S, Hiriart JB, Camma C, Wong GL, Marra F, et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol. 2017;67(3):577\u201384.","journal-title":"J Hepatol"},{"issue":"2","key":"713_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Duarte-Rojo A, Patel K, Asrani SK, Alsawas M, Dranoff JA, et al. AASLD practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(2):672\u2013724.","journal-title":"Hepatology"},{"issue":"8","key":"713_CR24","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.dld.2017.03.013","volume":"49","author":"L Xu","year":"2017","unstructured":"Xu L, Lu W, Li P, Shen F, Mi YQ, Fan JG. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Dig Liver Dis. 2017;49(8):910\u20137.","journal-title":"Dig Liver Dis"},{"issue":"8","key":"713_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182784","volume":"12","author":"BG Jun","year":"2017","unstructured":"Jun BG, Park WY, Park EJ, Jang JY, Jeong SW, Lee SH, et al. A prospective comparative assessment of the accuracy of the fibroscan in evaluating liver steatosis. PLoS One. 2017;12(8):e0182784.","journal-title":"PLoS One"},{"issue":"50","key":"713_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013636","volume":"97","author":"SB Ahn","year":"2018","unstructured":"Ahn SB, Jun DW, Kang BK, Kim M, Chang M, Nam E. Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Medicine (Baltimore). 2018;97(50):e13636.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"713_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-014-0372-6","volume":"16","author":"A Bonder","year":"2014","unstructured":"Bonder A, Afdhal N. Utilization of fibroscan in clinical practice. Curr Gastroenterol Rep. 2014;16(2):372.","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"713_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1148\/radiol.2015150619","volume":"276","author":"RG Barr","year":"2015","unstructured":"Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-Tsao G, Rubin J, et al. Elastography assessment of liver fibrosis: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2015;276(3):845\u201361.","journal-title":"Radiology"},{"issue":"6","key":"713_CR29","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/j.gastro.2017.03.016","volume":"152","author":"S Singh","year":"2017","unstructured":"Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American gastroenterological association institute technical review on the role of elastography in chronic liver diseases. Gastroenterology. 2017;152(6):1544\u201377.","journal-title":"Gastroenterology"},{"issue":"1","key":"713_CR30","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220553","volume":"307","author":"G Ferraioli","year":"2023","unstructured":"Ferraioli G, Barr RG. Interpreting liver stiffness values in clinical practice: is histologic classification necessary for clinical relevance? Radiology. 2023;307(1):e220553.","journal-title":"Radiology"},{"issue":"3","key":"713_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743\u201352.","journal-title":"J Hepatol"},{"issue":"4","key":"713_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VIIF. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959\u201374.","journal-title":"J Hepatol"},{"issue":"9","key":"713_CR33","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"713_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4330\/wjc.v16.i7.380","volume":"16","author":"A Batta","year":"2024","unstructured":"Batta A, Hatwal J. Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: a cause for concern! World J Cardiol. 2024;16(7):380\u20134.","journal-title":"World J Cardiol"},{"issue":"5","key":"713_CR35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161(5):1657\u201369.","journal-title":"Gastroenterology"},{"issue":"5","key":"713_CR36","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. Aasld practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835.","journal-title":"Hepatology"},{"issue":"Suppl","key":"713_CR37","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.3350\/cmh.2024.0392","volume":"30","author":"YE Chon","year":"2024","unstructured":"Chon YE, Jin YJ, An J, Kim HY, Choi M, Jun DW, et al. Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Mol Hepatol. 2024;30(Suppl):S117\u201333.","journal-title":"Clin Mol Hepatol"},{"key":"713_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2025.02.018","author":"T Vidal-Trecan","year":"2025","unstructured":"Vidal-Trecan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, et al. Effectiveness of six international guidelines using Fibrosis-4 and fibroscan for risk stratification of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes. Clin Gastroenterol Hepatol. 2025. https:\/\/doi.org\/10.1016\/j.cgh.2025.02.018.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"713_CR39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2021.12.031","volume":"76","author":"J Boursier","year":"2022","unstructured":"Boursier J, Hagstr\u00f6m H, Ekstedt M, Moreau C, Bonacci M, Cure S, et al. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events. J Hepatol. 2022;76(5):1013\u201320.","journal-title":"J Hepatol"},{"issue":"4","key":"713_CR40","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1097\/HEP.0000000000000023","volume":"77","author":"E Vilar-Gomez","year":"2023","unstructured":"Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Samala N, Chalasani N. CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population. Hepatology. 2023;77(4):1241\u201352.","journal-title":"Hepatology"},{"issue":"6","key":"713_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/jgh.14963","volume":"35","author":"TH Nguyen","year":"2020","unstructured":"Nguyen TH, Wardell R, Chitturi S, Teoh N, Farrell G. When the liver gets stiff, the tough get moving. J Gastroenterol Hepatol. 2020;35(6):953\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"713_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/liv.14301","volume":"40","author":"S Shili-Masmoudi","year":"2020","unstructured":"Shili-Masmoudi S, Wong GL, Hiriart JB, Liu K, Chermak F, Shu SS, et al. Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease. Liver Int. 2020;40(3):581\u20139.","journal-title":"Liver Int"},{"issue":"12","key":"713_CR43","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s11695-015-1696-5","volume":"25","author":"S Morita","year":"2015","unstructured":"Morita S, Neto Dde S, Morita FH, Morita NK, Lobo SM. Prevalence of non-alcoholic fatty liver disease and steatohepatitis risk factors in patients undergoing bariatric surgery. Obes Surg. 2015;25(12):2335\u201343.","journal-title":"Obes Surg"},{"issue":"1","key":"713_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063959","volume":"13","author":"C Mettananda","year":"2023","unstructured":"Mettananda C, Egodage T, Dantanarayana C, Fernando R, Ranaweera L, Luke N, et al. Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study. BMJ Open. 2023;13(1):e063959.","journal-title":"BMJ Open"},{"issue":"2","key":"713_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2337\/dc20-1997","volume":"44","author":"R Lomonaco","year":"2021","unstructured":"Lomonaco R, Godinez Leiva E, Bril F, Shrestha S, Mansour L, Budd J, et al. Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening. Diabetes Care. 2021;44(2):399\u2013406.","journal-title":"Diabetes Care"},{"issue":"7","key":"713_CR46","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/dc22-2048","volume":"46","author":"L Castera","year":"2023","unstructured":"Castera L, Laouenan C, Vallet-Pichard A, Vidal-Tr\u00e9can T, Manchon P, Paradis V, et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diabetes Care. 2023;46(7):1354\u201362.","journal-title":"Diabetes Care"},{"issue":"12","key":"713_CR47","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.14309\/ajg.0000000000001906","volume":"117","author":"P Vutien","year":"2022","unstructured":"Vutien P, Berry K, Feng Z, VoPham T, He Q, Green PK, et al. Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension. Am J Gastroenterol. 2022;117(12):1999\u20132008.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"713_CR48","volume":"2010","author":"NC Chavez-Tapia","year":"2010","unstructured":"Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;2010(1):CD007340.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"713_CR49","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1007\/s11695-022-06011-1","volume":"32","author":"H Zhou","year":"2022","unstructured":"Zhou H, Luo P, Li P, Wang G, Yi X, Fu Z, et al. Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis. Obes Surg. 2022;32(6):1872\u201383.","journal-title":"Obes Surg"},{"issue":"2","key":"713_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11695-020-04977-4","volume":"31","author":"L Agarwal","year":"2021","unstructured":"Agarwal L, Aggarwal S, Shalimar, Yadav R, Dattagupta S, Garg H, et al. Bariatric surgery in nonalcoholic fatty liver disease (NAFLD): impact assessment using paired liver biopsy and fibroscan. Obes Surg. 2021;31(2):617\u201326.","journal-title":"Obes Surg"},{"issue":"1","key":"713_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01344-6","volume":"16","author":"G Petralli","year":"2024","unstructured":"Petralli G, Raggi F, Zoppo AD, Rovera C, Salvati A, Brunetto MR, et al. Response to semaglutide of non-drinker subjects with type 2 diabetes. Diabetol Metab Syndr. 2024;16(1):103.","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"713_CR52","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/MEG.0000000000000392","volume":"27","author":"M Fernandez","year":"2015","unstructured":"Fernandez M, Trepo E, Degre D, Gustot T, Verset L, Demetter P, et al. Transient elastography using fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. Eur J Gastroenterol Hepatol. 2015;27(9):1074\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"713_CR53","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S2468-1253(18)30124-9","volume":"3","author":"E Nguyen-Khac","year":"2018","unstructured":"Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, et al. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3(9):614\u201325.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"713_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","volume":"119","author":"LL Jophlin","year":"2024","unstructured":"Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, et al. ACG clinical guideline: Alcohol-associated liver disease. Am J Gastroenterol. 2024;119(1):30\u201354.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"713_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jhep.2024.02.019","volume":"81","author":"KH Thorhauge","year":"2024","unstructured":"Thorhauge KH, Semmler G, Johansen S, Lindvig KP, Kj\u00e6rgaard M, Hansen JK, et al. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease. J Hepatol. 2024;81(1):23\u201332.","journal-title":"J Hepatol"},{"issue":"4","key":"713_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","volume":"10","author":"A Liguori","year":"2025","unstructured":"Liguori A, Zoncape M, Casazza G, Easterbrook P, Tsochatzis EA. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(4):332\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"713_CR57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/hep.24121","volume":"53","author":"KS Jung","year":"2011","unstructured":"Jung KS, Kim SU, Ahn SH, Park YN, Kim DY, Park JY, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011;53(3):885\u201394.","journal-title":"Hepatology"},{"issue":"Suppl","key":"713_CR58","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.3350\/cmh.2024.0163","volume":"30","author":"YJ Jin","year":"2024","unstructured":"Jin YJ, Kim HY, Suh YJ, Lee CH, Yu JH, Kim MN, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: systematic review and meta-analysis. Clin Mol Hepatol. 2024;30(Suppl):S159\u201371.","journal-title":"Clin Mol Hepatol"},{"issue":"11","key":"713_CR59","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1111\/j.1572-0241.2007.01466.x","volume":"102","author":"AA Shaheen","year":"2007","unstructured":"Shaheen AA, Wan AF, Myers RP. Fibrotest and fibroscan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007;102(11):2589\u2013600.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"713_CR60","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343\u201350.","journal-title":"Gastroenterology"},{"key":"713_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030602","author":"N Rodprasert","year":"2023","unstructured":"Rodprasert N, Hongboontry T, Cherdchoochart C, Chaiteerakij R. Association between liver stiffness and liver-related events in HCV-infected patients after successful treatment with direct-acting antivirals. Medicina (B Aires). 2023. https:\/\/doi.org\/10.3390\/medicina59030602.","journal-title":"Medicina (B Aires)"},{"key":"713_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/v16091439","author":"F Morisco","year":"2024","unstructured":"Morisco F, Federico A, Marignani M, Lombardo FL, Cossiga V, Ranieri L, et al. Prediction of clinical trajectory in HCV-related ACLD after SVR: role of liver stiffness in a 5-Years prospective study. Viruses. 2024. https:\/\/doi.org\/10.3390\/v16091439.","journal-title":"Viruses"},{"issue":"39","key":"713_CR63","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.3748\/wjg.v29.i39.5503","volume":"29","author":"H Chen","year":"2023","unstructured":"Chen H, Shen Y, Wu SD, Zhu Q, Weng CZ, Zhang J, et al. Diagnostic role of transient elastography in patients with autoimmune liver diseases: a systematic review and meta-analysis. World J Gastroenterol. 2023;29(39):5503\u201325.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"713_CR64","first-page":"265","volume":"117","author":"N Marcos Carrasco","year":"2025","unstructured":"Marcos Carrasco N, Lopez Jerez A, Garrido E, Garcia Gonzalez M. Estimation of liver fibrosis using elastography in cholestatic diseases: systematic review and meta-analysis. Rev Esp Enferm Dig. 2025;117(5):265\u201373.","journal-title":"Rev Esp Enferm Dig"},{"issue":"6","key":"713_CR65","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","volume":"77","author":"C Corpechot","year":"2022","unstructured":"Corpechot C, Carrat F, Gaouar F, Chau F, Hirschfield G, Gulamhusein A, et al. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J Hepatol. 2022;77(6):1545\u201353.","journal-title":"J Hepatol"},{"issue":"12","key":"713_CR66","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.cgh.2024.06.035","volume":"22","author":"L Lam","year":"2024","unstructured":"Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, et al. Dynamics of liver stiffness measurement and clinical course of primary biliary cholangitis. Clin Gastroenterol Hepatol. 2024;22(12):2432\u2013e412.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"713_CR67","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","volume":"146","author":"C Corpechot","year":"2014","unstructured":"Corpechot C, Gaouar F, El Naggar A, Kemgang A, Wendum D, Poupon R, et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology. 2014;146(4):970\u20139. quiz e15-6.","journal-title":"Gastroenterology"},{"issue":"6","key":"713_CR68","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193\u2013213.","journal-title":"Hepatology"},{"issue":"4","key":"713_CR69","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of","year":"2015","unstructured":"European Association for the Study of. The L. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63(4):971\u20131004.","journal-title":"J Hepatol"},{"key":"713_CR70","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.12659\/MSM.907300","volume":"23","author":"L Guo","year":"2017","unstructured":"Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient elastography (FibroScan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients. Med Sci Monit. 2017;23:5106\u201312.","journal-title":"Med Sci Monit"},{"issue":"Suppl","key":"713_CR71","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.3350\/cmh.2024.0586","volume":"30","author":"J An","year":"2024","unstructured":"An J, Chon YE, Kim G, Kim MN, Kim HY, Lee HA, et al. Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis. Clin Mol Hepatol. 2024;30(Suppl):S134\u201346.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"713_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02430-7","volume":"22","author":"N Alkhouri","year":"2022","unstructured":"Alkhouri N, Almomani A, Le P, Payne JY, Asaad I, Sakkal C, et al. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. BMC Gastroenterol. 2022;22(1):366.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"713_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101755","volume":"46","author":"BR Chen","year":"2022","unstructured":"Chen BR, Pan CQ. Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. Clin Res Hepatol Gastroenterol. 2022;46(1):101755.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"22","key":"713_CR74","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.3748\/wjg.v21.i22.6931","volume":"21","author":"QL Shen","year":"2015","unstructured":"Shen QL, Chen YJ, Wang ZM, Zhang TC, Pang WB, Shu J, et al. Assessment of liver fibrosis by fibroscan as compared to liver biopsy in biliary atresia. World J Gastroenterol. 2015;21(22):6931\u20136.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"713_CR75","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00383-022-05137-8","volume":"38","author":"F Yeung","year":"2022","unstructured":"Yeung F, Fung ACH, Chung PHY, Chu YY, Seto WK, Wong KKY. Long-term follow-up of biliary atresia using liver transient elastography. Pediatr Surg Int. 2022;38(7):1013\u20138.","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"713_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjh.16047","volume":"187","author":"G Ben Yakov","year":"2019","unstructured":"Ben Yakov G, Sharma D, Alao H, Surana P, Kapuria D, Etzion O, et al. Vibration controlled transient elastography (Fibroscan\u00ae) in sickle cell liver disease - could we strike while the liver is hard? Br J Haematol. 2019;187(1):117\u201323.","journal-title":"Br J Haematol"},{"issue":"5","key":"713_CR77","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/2150135120935418","volume":"11","author":"S Talwar","year":"2020","unstructured":"Talwar S, Gudala V, Joshi R, Shalimar DM, Madhusudhan KS, Kalaivani M, et al. Noninvasive assessment of liver stiffness in patients undergoing the Fontan procedure. World J Pediatr Congenit Heart Surg. 2020;11(5):572\u20137.","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"11","key":"713_CR78","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i11.103178","volume":"31","author":"M Cuadros","year":"2025","unstructured":"Cuadros M, Abadia M, Castillo P, Martin-Arranz MD, Gonzalo N, Romero M, et al. Role of transient elastography in the diagnosis and prognosis of Fontan-associated liver disease. World J Gastroenterol. 2025;31(11):103178.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"713_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101368","volume":"14","author":"A Choudhury","year":"2024","unstructured":"Choudhury A, Singh SP, Desmukh A, Sahoo B, Eslam M. Post-liver transplant metabolic syndrome. J Clin Exp Hepatol. 2024;14(4):101368.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"713_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/lt.26568","volume":"29","author":"T Arshad","year":"2023","unstructured":"Arshad T, Bhati CS, Bui AT, Tseng M, Vainer D, Miller A, et al. Evaluation of liver stiffness measurement-based scores in liver transplantation recipients. Liver Transpl. 2023;29(2):196\u2013205.","journal-title":"Liver Transpl"},{"issue":"13","key":"713_CR81","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3748\/wjg.v24.i13.1386","volume":"24","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Nagai S, Safwan M, Liang C, Ohkohchi N. Thrombocytopenia after liver transplantation: should we care? World J Gastroenterol. 2018;24(13):1386\u201397.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"713_CR82","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1111\/liv.16085","volume":"44","author":"L Mart\u00ednez-Arenas","year":"2024","unstructured":"Mart\u00ednez-Arenas L, Vinaixa C, Conde I, Lorente S, D\u00edaz-Fontenla F, Marques P, et al. FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH. Liver Int. 2024;44(12):3174\u201382.","journal-title":"Liver Int"},{"issue":"1","key":"713_CR83","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.31688","volume":"74","author":"L Elkrief","year":"2021","unstructured":"Elkrief L, Lazareth M, Chevret S, Paradis V, Magaz M, Blaise L, et al. Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension. Hepatology. 2021;74(1):364\u201378.","journal-title":"Hepatology"},{"issue":"12","key":"713_CR84","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/00365521.2021.1968485","volume":"56","author":"J Ferreira-Silva","year":"2021","unstructured":"Ferreira-Silva J, Gaspar R, Liberal R, Cardoso H, Macedo G. Transient splenic elastography predicts high-risk esophageal varices in patients with non-cirrhotic portal hypertension. Scand J Gastroenterol. 2021;56(12):1462\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"713_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dld.2022.09.018","volume":"55","author":"J Ferreira-Silva","year":"2023","unstructured":"Ferreira-Silva J, Gaspar R, Liberal R, Cardoso H, Macedo G. Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension. Dig Liver Dis. 2023;55(1):75\u201380.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"713_CR86","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1007\/s10067-021-05678-8","volume":"40","author":"P Bafna","year":"2021","unstructured":"Bafna P, Sahoo RR, Hazarika K, Manoj M, Rungta S, Wakhlu A. Prevalence of liver fibrosis by fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis. Clin Rheumatol. 2021;40(9):3605\u201313.","journal-title":"Clin Rheumatol"},{"key":"713_CR87","first-page":"21","volume":"8","author":"HS Cheng","year":"2018","unstructured":"Cheng HS, Rademaker M. Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography. Psoriasis (Auckl). 2018;8:21\u20139.","journal-title":"Psoriasis (Auckl)"},{"key":"713_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154752","volume":"121","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. Metabolism. 2021;121:154752.","journal-title":"Metabolism"},{"key":"713_CR89","doi-asserted-by":"crossref","unstructured":"Velji-Ibrahim J, Woodard J, Alden J, Abrams GA. FibroScan discordance with liver biopsy significantly overestimates advanced fibrosis and cirrhosis in MASLD subjects with class 3 obesity: implications for Resmetirom eligibility. J Clin Gastroenterol. 2025.","DOI":"10.1097\/MCG.0000000000002132"},{"key":"713_CR90","doi-asserted-by":"publisher","DOI":"10.1055\/a-2592-6109","author":"EK Messer","year":"2025","unstructured":"Messer EK, Petroff D, Schattenberg J, Zeuzem S, von der Ohe M, Ludwig L, et al. Evaluating resmetirom eligibility among patients with MASH: insights from the German steatotic liver disease-registry. Z Gastroenterol. 2025. https:\/\/doi.org\/10.1055\/a-2592-6109.","journal-title":"Z Gastroenterol"},{"issue":"4","key":"713_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13945","volume":"75","author":"TH Huang","year":"2021","unstructured":"Huang TH, Lin MT, Wang JH, Chang KC, Yen YH, Kuo FY, et al. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction. Int J Clin Pract. 2021;75(4):e13945.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"713_CR92","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10396-022-01239-x","volume":"49","author":"A Kumar","year":"2022","unstructured":"Kumar A, Maruyama H, Arora A, Sharma P, Anikhindi SA, Bansal N, et al. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis. J Med Ultrason (2001). 2022;49(3):333\u201346.","journal-title":"J Med Ultrason (2001)"},{"issue":"7","key":"713_CR93","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1148\/rg.2016160042","volume":"36","author":"A Srinivasa Babu","year":"2016","unstructured":"Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, et al. Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics. 2016;36(7):1987\u20132006.","journal-title":"Radiographics"},{"issue":"2","key":"713_CR94","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.22056","volume":"47","author":"A Sagir","year":"2008","unstructured":"Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47(2):592\u20135.","journal-title":"Hepatology"},{"issue":"5","key":"713_CR95","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","volume":"14","author":"B Coco","year":"2007","unstructured":"Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007;14(5):360\u20139.","journal-title":"J Viral Hepat"},{"issue":"2","key":"713_CR96","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/hep.22007","volume":"47","author":"U Arena","year":"2008","unstructured":"Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47(2):380\u20134.","journal-title":"Hepatology"},{"issue":"2","key":"713_CR97","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","volume":"70","author":"C Moreno","year":"2019","unstructured":"Moreno C, Mueller S, Szabo G. Non-invasive diagnosis and biomarkers in alcohol-related liver disease. J Hepatol. 2019;70(2):273\u201383.","journal-title":"J Hepatol"},{"issue":"8","key":"713_CR98","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3748\/wjg.v16.i8.966","volume":"16","author":"S Mueller","year":"2010","unstructured":"Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010;16(8):966\u201372.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"713_CR99","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/j.1530-0277.2012.01737.x","volume":"36","author":"JB Trabut","year":"2012","unstructured":"Trabut JB, Thepot V, Nalpas B, Lavielle B, Cosconea S, Corouge M, et al. Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcohol Clin Exp Res. 2012;36(8):1407\u201311.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"713_CR100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/alcalc\/agw053","volume":"52","author":"E Gianni","year":"2017","unstructured":"Gianni E, Forte P, Galli V, Razzolini G, Bardazzi G, Annese V. Prospective evaluation of liver stiffness using transient elastography in alcoholic patients following abstinence. Alcohol Alcohol. 2017;52(1):42\u20137.","journal-title":"Alcohol Alcohol"},{"issue":"7","key":"713_CR101","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cgh.2021.02.021","volume":"20","author":"L Legros","year":"2022","unstructured":"Legros L, Bardou-Jacquet E, Turlin B, Michalak S, Hamonic S, Le Gruyer A, et al. Transient elastography accurately screens for compensated advanced chronic liver disease in patients with ongoing or recent alcohol withdrawal. Clin Gastroenterol Hepatol. 2022;20(7):1542\u201352. e6.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"713_CR102","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","volume":"52","author":"G Millonig","year":"2010","unstructured":"Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52(2):206\u201310.","journal-title":"J Hepatol"},{"issue":"6","key":"713_CR103","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/eurjhf\/hfs044","volume":"14","author":"I Hopper","year":"2012","unstructured":"Hopper I, Kemp W, Porapakkham P, Sata Y, Condon E, Skiba M, et al. Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography. Eur J Heart Fail. 2012;14(6):621\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"713_CR104","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.22577","volume":"48","author":"G Millonig","year":"2008","unstructured":"Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48(5):1718\u201323.","journal-title":"Hepatology"},{"issue":"5","key":"713_CR105","first-page":"372","volume":"11","author":"A Trifan","year":"2011","unstructured":"Trifan A, Sfarti C, Cojocariu C, Dimache M, Cretu M, Hutanasu C, et al. Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis. Hepat Mon. 2011;11(5):372\u20135.","journal-title":"Hepat Mon"},{"issue":"1","key":"713_CR106","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00535-010-0290-9","volume":"46","author":"Y Yashima","year":"2011","unstructured":"Yashima Y, Tsujino T, Masuzaki R, Nakai Y, Hirano K, Tateishi R, et al. Increased liver elasticity in patients with biliary obstruction. J Gastroenterol. 2011;46(1):86\u201391.","journal-title":"J Gastroenterol"},{"issue":"1","key":"713_CR107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"713_CR108","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/2050640619865133","volume":"7","author":"K Staufer","year":"2019","unstructured":"Staufer K, Halilbasic E, Spindelboeck W, Eilenberg M, Prager G, Stadlbauer V, et al. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United Eur Gastroenterol J. 2019;7(8):1113\u201323.","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"713_CR109","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"4","key":"713_CR110","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1665-2681(19)31341-9","volume":"12","author":"GL Wong","year":"2013","unstructured":"Wong GL, Vergniol J, Lo P, Wai-Sun Wong V, Foucher J, Le Bail B, et al. Non-invasive assessment of liver fibrosis with transient elastography (FibroScan(R)): applying the cut-offs of M probe to XL probe. Ann Hepatol. 2013;12(4):570\u201380.","journal-title":"Ann Hepatol"},{"key":"713_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10100795","author":"M Giuffre","year":"2020","unstructured":"Giuffre M, Giuricin M, Bonazza D, Rosso N, Giraudi PJ, Masutti F, et al. Optimization of point-shear wave elastography by skin-to-liver distance to assess liver fibrosis in patients undergoing bariatric surgery. Diagnostics. 2020. https:\/\/doi.org\/10.3390\/diagnostics10100795.","journal-title":"Diagnostics"},{"issue":"1","key":"713_CR112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hep.24624","volume":"55","author":"RP Myers","year":"2012","unstructured":"Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, et al. Feasibility and diagnostic performance of the fibroscan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology. 2012;55(1):199\u2013208.","journal-title":"Hepatology"},{"issue":"12","key":"713_CR113","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1007\/s11695-020-05002-4","volume":"30","author":"MM Puthenpura","year":"2020","unstructured":"Puthenpura MM, Patel V, Fam J, Katz L, Tichansky DS, Myers S. The use of transient elastography technology in the bariatric patient: a review of the literature. Obes Surg. 2020;30(12):5108\u201316.","journal-title":"Obes Surg"},{"issue":"1","key":"713_CR114","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soard.2017.09.005","volume":"14","author":"H Garg","year":"2018","unstructured":"Garg H, Aggarwal S, Shalimar, Yadav R, Datta Gupta S, Agarwal L, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis. 2018;14(1):81\u201391.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"713_CR115","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2024.11.049","volume":"82","author":"P Cales","year":"2025","unstructured":"Cales P, Canivet CM, Costentin C, Lannes A, Oberti F, Fouchard I, et al. A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD. J Hepatol. 2025;82(5):794\u2013804.","journal-title":"J Hepatol"},{"key":"713_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1499013","volume":"11","author":"S Dawod","year":"2024","unstructured":"Dawod S, Brown K. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Front Med. 2024;11:1499013.","journal-title":"Front Med"},{"issue":"4","key":"713_CR117","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan WK, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5(4):362\u201373.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"713_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.869190","volume":"9","author":"JS Lee","year":"2022","unstructured":"Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, et al. Comparison of FibroScan-aspartate aminotransferase (FAST) score and other non-invasive surrogates in predicting high-risk non-alcoholic steatohepatitis criteria. Front Med. 2022;9:869190.","journal-title":"Front Med"},{"issue":"4","key":"713_CR119","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.gastha.2024.02.006","volume":"3","author":"G Karim","year":"2024","unstructured":"Karim G, Giri D, Wyatt B, Dinani AM. A real-world experience utilizing the FAST score to identify patients with nonalcoholic steatohepatitis fibrosis. Gastro Hep Adv. 2024;3(4):476\u201381.","journal-title":"Gastro Hep Adv"},{"key":"713_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102310","volume":"66","author":"V Wai-Sun Wong","year":"2023","unstructured":"Wai-Sun Wong V, Anstee QM, Nitze LM, Geerts A, George J, Nolasco V, et al. FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial. EClinicalMedicine. 2023;66:102310.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"713_CR121","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","volume":"78","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Foucquier J, Younossi ZM, Harrison SA, Newsome PN, Chan WK, et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based agile scores. J Hepatol. 2023;78(2):247\u201359.","journal-title":"J Hepatol"},{"issue":"5","key":"713_CR122","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/HEP.0000000000000694","volume":"79","author":"A Dalbeni","year":"2024","unstructured":"Dalbeni A, Lombardi R, Henrique M, Zoncape M, Pennisi G, Petta S, et al. Diagnostic accuracy of AGILE 3\u2009+\u2009score for advanced fibrosis in patients with NAFLD: a systematic review and meta-analysis. Hepatology. 2024;79(5):1107\u201316.","journal-title":"Hepatology"},{"issue":"5","key":"713_CR123","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000055","volume":"7","author":"M Noureddin","year":"2023","unstructured":"Noureddin M, Mena E, Vuppalanchi R, Samala N, Wong M, Pacheco F, et al. Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the agile 3 + and 4 scores. Hepatol Commun. 2023;7(5): e0055.","journal-title":"Hepatol Commun."},{"issue":"5","key":"713_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303971","volume":"19","author":"MG Taru","year":"2024","unstructured":"Taru MG, Tefas C, Neamti L, Minciuna I, Taru V, Maniu A, et al. FAST and agile-the MASLD drift: validation of agile 3+, agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent Caucasian origin. PLoS One. 2024;19(5):e0303971.","journal-title":"PLoS One"},{"issue":"2","key":"713_CR125","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/jgh.16076","volume":"38","author":"A Nogami","year":"2023","unstructured":"Nogami A, Iwaki M, Kobayashi T, Honda Y, Ogawa Y, Imajo K, et al. Real-world assessment of SmartExam, a novel fibroscan computational method: a retrospective single-center cohort study. J Gastroenterol Hepatol. 2023;38(2):321\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"713_CR126","doi-asserted-by":"crossref","unstructured":"Alkhouri N, Cheuk-Fung Yip T, Castera L, Takawy M, Adams LA, Verma N et al. ALADDIN: A machine learning approach to enhance the prediction of significant fibrosis or higher in metabolic Dysfunction-Associated steatotic liver disease. Am J Gastroenterol. 2025: 10-14309.","DOI":"10.14309\/ajg.0000000000003432"}],"container-title":["Current Hepatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-025-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11901-025-00713-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-025-00713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:02:33Z","timestamp":1769410953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11901-025-00713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1007\/s11901-025-00713-7","relation":{},"ISSN":["2195-9595"],"issn-type":[{"value":"2195-9595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"5 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article did not require approval of Ethics committee or Internal Review Boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This article does not contain any studies with human or animal studies performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}